Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Mycobacterium Tuberculosis Vaccine, Live Attenuated
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : IAVI
Deal Size : Inapplicable
Deal Type : Inapplicable
IAVI, Biofabri Start IMAGINE Trial for Tuberculosis Vaccine Candidate MTBVAC
Details : MTBVAC is a live-attenuated vaccine candidate, derived from a human isolate of Mycobacterium tuberculosis. It is being evaluated to prevent active TB lung disease in adolescents and adults.
Product Name : MTBVAC
Product Type : Vaccine
Upfront Cash : Inapplicable
February 26, 2025
Lead Product(s) : Mycobacterium Tuberculosis Vaccine, Live Attenuated
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : IAVI
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Mycobacterium Tuberculosis Vaccine, Live Attenuated
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : IAVI
Deal Size : Undisclosed
Deal Type : Agreement
Zendal and IAVI Announce Expanded Agreement to Partner on Development of TB Vaccine Candidate MTBVAC
Details : Under the agreement, IAVI is supporting development, global regulatory strategy, resource mobilization, and access planning for the adolescent/adult tuberculosis (TB) vaccine candidate MTBVAC.
Product Name : MTBVAC
Product Type : Vaccine
Upfront Cash : Undisclosed
May 17, 2023
Lead Product(s) : Mycobacterium Tuberculosis Vaccine, Live Attenuated
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : IAVI
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Mycobacterium Tuberculosis Vaccine, Live Attenuated,BCG Vaccine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Bharat Biotech
Deal Size : Undisclosed
Deal Type : Partnership
Details : This agreement between BHARAT BIOTECH and BIOFABRI would guarantee the worldwide production and the supply of the future vaccine, MTBVAC in more than 70 countries with a high TB incidence, such as India, country with the highest TB burden in the world, w...
Product Name : MTBVAC
Product Type : Vaccine
Upfront Cash : Undisclosed
March 16, 2022
Lead Product(s) : Mycobacterium Tuberculosis Vaccine, Live Attenuated,BCG Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Bharat Biotech
Deal Size : Undisclosed
Deal Type : Partnership